{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T17:53:31Z","timestamp":1790790811312,"version":"4.1.0"},"reference-count":101,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.ejphar.2021.174376","type":"journal-article","created":{"date-parts":[[2021,7,22]],"date-time":"2021-07-22T18:20:59Z","timestamp":1626978059000},"page":"174376","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"special_numbering":"C","title":["Recent advances, novel targets and treatments for cholelithiasis; a narrative review"],"prefix":"10.1016","volume":"908","author":[{"given":"Swarne","family":"E","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.S.","family":"Srikanth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7662-4413","authenticated-orcid":false,"given":"Ayachit","family":"Shreyas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sneha","family":"Desai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3212-0774","authenticated-orcid":false,"given":"Seema","family":"Mehdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.V.","family":"Gangadharappa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Suman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7538-0798","authenticated-orcid":false,"given":"K.L.","family":"Krishna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2021.174376_bib1","series-title":"LDL, and HDL Levels on Gallstone Cholesterol Concentration","first-page":"187","article-title":"The effects of serum cholesterol","volume":"29","author":"Access","year":"2013"},{"key":"10.1016\/j.ejphar.2021.174376_bib2","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1517\/14656566.2011.629995","article-title":"Statins as potential treatment for cholesterol gallstones: an attempt to understand the underlying mechanism of actions","volume":"12","author":"Ahmed","year":"2011","journal-title":"Expet Opin. Pharmacother."},{"key":"10.1016\/j.ejphar.2021.174376_bib3","series-title":"Aqueous Extract from Spanish Black Radish ( Raphanus sativus L . Var . niger ) Induces Detoxification Enzymes in the HepG2 2003","author":"Arnes","year":"2007"},{"key":"10.1016\/j.ejphar.2021.174376_bib4","series-title":"SC. Gastroenterology","author":"Asai","year":"2017"},{"key":"10.1016\/j.ejphar.2021.174376_bib5","series-title":"Assessment of Gallstone Predictor\u00a0: Comparative Analysis of Ultrasonographic and Biochemical Parameters","first-page":"1","author":"Aslam","year":"2013"},{"key":"10.1016\/j.ejphar.2021.174376_bib6","doi-asserted-by":"crossref","first-page":"100288","DOI":"10.1016\/j.obmed.2020.100288","article-title":"Protective effect of Juniperus Communis extract by inhibition of Pro-nucleating agents in lithogenic diet induced cholelithiasis in mice","volume":"20","author":"Bais","year":"2020","journal-title":"Obes. Med."},{"key":"10.1016\/j.ejphar.2021.174376_bib7","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/j.1365-2362.2006.01607.x","article-title":"Decreased hepatic expression of PPAR-\u03b3 coactivator-1 in cholesterol cholelithiasis","volume":"36","author":"Bertolotti","year":"2006","journal-title":"Eur. J. Clin. Invest."},{"key":"10.1016\/j.ejphar.2021.174376_bib8","series-title":"Serum Adiponectin and Progranulin Levels Are Associated with Gallstone Disease","first-page":"559","author":"Breitfeld","year":"2014"},{"key":"10.1016\/j.ejphar.2021.174376_bib9","series-title":"Liver and Intestinal Protective Effects of Castanea Sativa Mill. Bark Extract in High-Fat Diet Rats","first-page":"1","author":"Budriesi","year":"2018"},{"key":"10.1016\/j.ejphar.2021.174376_bib10","series-title":"Defective Hepatocyte Aquaporin-8 Expression and Reduced Canalicular Membrane Water Permeability in Estrogen-Induced cholestasis","first-page":"905","author":"Carreras","year":"2007"},{"key":"10.1016\/j.ejphar.2021.174376_bib11","series-title":"Raphanus sativus L . var niger as a Source of Phytochemicals for the Prevention of Cholesterol Gallstones","first-page":"167","volume":"171","author":"Castro-torres","year":"2014"},{"key":"10.1016\/j.ejphar.2021.174376_bib12","article-title":"Mechanisms underlying the prevention and treatment of cholelithiasis using traditional Chinese medicine. Evidence-based complement","author":"Chen","year":"2019","journal-title":"Alternative Med."},{"key":"10.1016\/j.ejphar.2021.174376_bib13","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1038\/labinvest.2014.140","article-title":"Cholesterol gallstone disease\u00a0: focusing on the role of GB","volume":"95","author":"Chen","year":"2014","journal-title":"Lab. Invest."},{"key":"10.1016\/j.ejphar.2021.174376_bib14","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s13105-020-00751-3","article-title":"Altered absorptive function in the gall bladder during cholesterol gallstone formation is associated with abnormal NHE3 complex formation","volume":"76","author":"Chen","year":"2020","journal-title":"J. Physiol. Biochem."},{"key":"10.1016\/j.ejphar.2021.174376_bib15","article-title":"Phosphorylation and subcellular localization of Na +\/H + exchanger isoform 3 ( NHE 3 ) are associated with altered GB absorptive function after formation of cholesterol gallstones","volume":"3","author":"Chen","year":"2016","journal-title":"J. Physiol. Biochem."},{"key":"10.1016\/j.ejphar.2021.174376_bib16","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.ajpath.2016.12.013","article-title":"Activation of constitutive androstane receptor prevents cholesterol gallstone formation","volume":"187","author":"Cheng","year":"2017","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ejphar.2021.174376_bib17","series-title":"Probiotics and the BSH-Related Cholesterol Lowering Mechanism\u00a0: a Jekyll and Hyde Scenario 8551","first-page":"1","author":"Choi","year":"2014"},{"key":"10.1016\/j.ejphar.2021.174376_bib18","series-title":"Liver Steatosis , Gut-Liver Axis , Microbiome and Environmental Factors . A Never-Ending Bidirectional Cross-Talk","author":"Ciaula","year":"2020"},{"key":"10.1016\/j.ejphar.2021.174376_bib19","series-title":"Effects of Cholesterol on CCK-1 Receptors and Caveolin-3 Proteins Recycling in Human GB muscle","first-page":"742","author":"Cong","year":"2018"},{"key":"10.1016\/j.ejphar.2021.174376_bib20","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1194\/jlr.RA119000592","article-title":"A novel GPER antagonist protects against the formation of estrogen-induced cholesterol gallstones in female mice","volume":"61","author":"DeLeon","year":"2020","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.ejphar.2021.174376_bib21","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/MOG.0000000000000423","article-title":"An update on the pathogenesis of cholesterol gallstone disease","volume":"34","author":"Di Ciaula","year":"2018","journal-title":"Curr. Opin. Gastroenterol."},{"key":"10.1016\/j.ejphar.2021.174376_bib22","series-title":"Biliary Cholesterol Secretion\u00a0: More than a Simple ABC Importance of Biliary Cholesterol","first-page":"5936","volume":"16","author":"Dikkers","year":"2010"},{"key":"10.1016\/j.ejphar.2021.174376_bib23","series-title":"Evaluation of the Phytochemical , Antioxidant , Antibacterial and Anticancer Activity of Prunus domestica Fruit","first-page":"395","volume":"47","author":"El-beltagi","year":"2019"},{"key":"10.1016\/j.ejphar.2021.174376_bib24","series-title":"Relation of Coffee , Green Tea , and Caffeine Intake to Gallstone Disease in Middle-Aged Japanese Men Author ( s ): H . Ishizuka , H . Eguchi , T . Oda , S . Ogawa , K . Nakagawa , S . Honjo and S . Kono Published By","first-page":"401","author":"European","year":"2016"},{"key":"10.1016\/j.ejphar.2021.174376_bib25","series-title":"Prevalence and Ethnic Differences in GB Disease in the United States","first-page":"632","author":"Everhart","year":"1999"},{"key":"10.1016\/j.ejphar.2021.174376_bib26","article-title":"20 loci associated with gallstone disease","volume":"1\u201311","author":"Ferkingstad","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejphar.2021.174376_bib27","doi-asserted-by":"crossref","first-page":"8132","DOI":"10.1073\/pnas.0500269102","article-title":"The target of ezetimibe is Niemann-Pick C1-Like 1 (NPC1L1)","volume":"102","author":"Garcia-Calvo","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.ejphar.2021.174376_bib28","unstructured":"Gu, Q., Zhou, G., Xu, T., n.d. Risk Factors for Gallstone Disease in Shanghai 1\u20134."},{"key":"10.1016\/j.ejphar.2021.174376_bib29","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3390\/nu10091307","article-title":"Diet: cause or consequence of the microbial profile of cholelithiasis disease?","volume":"10","author":"Guti\u00e9rrez-D\u00edaz","year":"2018","journal-title":"Nutrients"},{"key":"10.1016\/j.ejphar.2021.174376_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jphs.2018.09.013","article-title":"PPAR\u03b3 overexpression regulates cholesterol metabolism in human L02 hepatocytes","volume":"139","author":"Han","year":"2019","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.ejphar.2021.174376_bib31","series-title":"Influence of Cholecystectomy on Symptoms","first-page":"964","volume":"78","author":"Hernt","year":"1991"},{"key":"10.1016\/j.ejphar.2021.174376_bib32","series-title":"Gallstone Disease , towards a Better Understanding and Clinical Practice","author":"Housset","year":"2017"},{"key":"10.1016\/j.ejphar.2021.174376_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-019-49095-z","article-title":"Combination treatment with n-3 polyunsaturated fatty acids and ursodeoxycholic acid dissolves cholesterol gallstones in mice","volume":"9","author":"Jang","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2021.174376_bib34","series-title":"Cholesterol Inhibits Spontaneous Action Potentials and Calcium Currents in guinea Pig GB Smooth Muscle","first-page":"1017","author":"Jennings","year":"2018"},{"key":"10.1016\/j.ejphar.2021.174376_bib35","series-title":"Relation of GB Motility to Viscosity and Composition of GB Bile in Patients with 229\u2013234","author":"J\u00fcngst","year":"2009"},{"key":"10.1016\/j.ejphar.2021.174376_bib36","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1111\/1758-2229.12319","article-title":"Interactions between the intestinal microbiota and bile acids in gallstones patients","volume":"7","author":"Keren","year":"2015","journal-title":"Environ. Microbiol. Rep."},{"key":"10.1016\/j.ejphar.2021.174376_bib37","series-title":"N-3 Polyunsaturated Fatty Acid Attenuates Cholesterol Gallstones by Suppressing Mucin Production with a High Cholesterol Diet in Mice","first-page":"1745","volume":"27","author":"Kim","year":"2012"},{"key":"10.1016\/j.ejphar.2021.174376_bib38","article-title":"Gallstones","volume":"2","author":"Lammert","year":"2016","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.ejphar.2021.174376_bib39","first-page":"475","volume":"vol. 484","author":"Lee","year":"2002"},{"key":"10.1016\/j.ejphar.2021.174376_bib40","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1001\/archinte.165.5.567","article-title":"Thiazide diuretics and the risk of GB disease requiring surgery in women","volume":"165","author":"Leitzmann","year":"2005","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.ejphar.2021.174376_bib41","series-title":"Human GB Mucin Accelerates Nucleation of Cholesterol in Artificial Bile","author":"Levy","year":"1984"},{"key":"10.1016\/j.ejphar.2021.174376_bib42","series-title":"Osteopontin Deficiency Protects Mice from Cholesterol Gallstone Formation by Reducing Expression of Intestinal NPC1L1","first-page":"1785","volume":"16","author":"Lin","year":"2017"},{"key":"10.1016\/j.ejphar.2021.174376_bib43","first-page":"1","article-title":"Osteopontin deficiency alters biliary homeostasis and protects against gallstone formation","volume":"6","author":"Lin","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2021.174376_bib44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejphar.2017.10.003","article-title":"Prevention of cholesterol gallstone disease by schaftoside in lithogenic diet-induced C57BL\/6 mouse model","volume":"815","author":"Liu","year":"2017","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2021.174376_bib45","doi-asserted-by":"crossref","first-page":"112776","DOI":"10.1016\/j.jep.2020.112776","article-title":"Schaftoside alleviates HFD-induced hepatic lipid accumulation in mice via upregulating farnesoid X receptor","volume":"255","author":"Liu","year":"2020","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.ejphar.2021.174376_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.mam.2017.06.002","article-title":"Interactions between gut bacteria and bile in health and disease","author":"Long","year":"2017","journal-title":"Mol. Aspect. Med."},{"key":"10.1016\/j.ejphar.2021.174376_bib47","series-title":"Alimentary Hyperlipidaemia in Rats","first-page":"587","article-title":"Antioxidant effect of squeezed juice from black radish ( Raphanus sativus L . var niger )","volume":"591","author":"Lugasi","year":"2005"},{"key":"10.1016\/j.ejphar.2021.174376_bib48","first-page":"425","article-title":"Basic and clinical reviews in basic and clinical","volume":"136","author":"Lynch","year":"2009","journal-title":"YGAST"},{"key":"10.1016\/j.ejphar.2021.174376_bib49","article-title":"NON surgical management OF cholelithyasis (pittashmari): a CASE STUDY Pharmaceutical standardization of two different dosage forms of savarnkara yoga and its efficacy on Shvitra (Vitiligo) View project Ayurvedic Case Reports View project","author":"Manani","year":"2020","journal-title":"Artic. World J. Pharm. Res."},{"key":"10.1016\/j.ejphar.2021.174376_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.cca.2006.08.036","article-title":"Role of diet in cholesterol gallstone formation","author":"M\u00e9ndez-S\u00e1nchez","year":"2007","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.ejphar.2021.174376_bib51","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1089\/jmf.2013.0090","article-title":"Castanea sativa Mill. Extract contracts GB and relaxes sphincter of oddi in Guinea Pig: a natural approach to biliary tract motility disorders","volume":"17","author":"Micucci","year":"2014","journal-title":"J. Med. Food"},{"issue":"12","key":"10.1016\/j.ejphar.2021.174376_bib52","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1097\/00042737-200412000-00011","article-title":"Effect of GB mucin on the crystallization of cholesterol in bile","volume":"16","author":"Mock","year":"2004","journal-title":"Eur. I Gastroenterol. Hepatol."},{"key":"10.1016\/j.ejphar.2021.174376_bib53","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S0039-6060(99)70202-3","article-title":"Octreotide stimulates Ca++ secretion by the GB: a risk factor for gallstones","volume":"125","author":"Moser","year":"1999","journal-title":"Surgery"},{"key":"10.1016\/j.ejphar.2021.174376_bib54","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.immuni.2019.07.002","article-title":"Neutrophil extracellular traps initiate gallstone formation","volume":"51","author":"Mu\u00f1oz","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.ejphar.2021.174376_bib55","first-page":"139","article-title":"Increased expression of mucin 5AC mRNA and decreased expression of epidermal growth-factor receptor mRNA in","volume":"214","author":"National","year":"2008","journal-title":"Gallstone Patients"},{"key":"10.1016\/j.ejphar.2021.174376_bib56","doi-asserted-by":"crossref","first-page":"170","DOI":"10.14309\/crj.2014.40","article-title":"Ceftriaxone-induced gallstones: case report and literature review","volume":"1","author":"Nayak","year":"2014","journal-title":"ACG Case Reports J"},{"key":"10.1016\/j.ejphar.2021.174376_bib57","article-title":"Inverse association between coffee consumption and risk of cholecystectomy in women but not in men","volume":"1\u20138","author":"Nordenvall","year":"2014","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ejphar.2021.174376_bib58","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/417821","article-title":"Risk factors for recurrence of symptomatic common bile duct stones after cholecystectomy","author":"Oak","year":"2012","journal-title":"Gastroenterol. Res. Pract."},{"key":"10.1016\/j.ejphar.2021.174376_bib59","series-title":"Loss of GB Interstitial Cajal-like Cells in Patients with cholelithiasis","first-page":"17","author":"Pasternak","year":"2013"},{"key":"10.1016\/j.ejphar.2021.174376_bib60","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/j.1528-1157.1983.tb04877.x","article-title":"A review of pharmacology and clinical use of piperine and its derivatives","volume":"24","author":"Pei","year":"1983","journal-title":"Epilepsia"},{"key":"10.1016\/j.ejphar.2021.174376_bib61","series-title":"Gallstones","first-page":"815","author":"Pier","year":"2007"},{"key":"10.1016\/j.ejphar.2021.174376_bib62","series-title":"GB Motility and Cholesterol Crystallization in Bile from Patients with Pigment and Cholesterol Gallstones","first-page":"317","author":"Portincasa","year":"2000"},{"key":"10.1016\/j.ejphar.2021.174376_bib63","series-title":"Medicinal Treatments of Cholesterol Gallstones\u00a0: Old , Current and New Perspectives","first-page":"1531","author":"Portincasa","year":"2009"},{"key":"10.1016\/j.ejphar.2021.174376_bib64","series-title":"Cholesterol Gallstone Disease","first-page":"368","author":"Portincasa","year":"2006"},{"key":"10.1016\/j.ejphar.2021.174376_bib65","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.2174\/0929867043364955","article-title":"Chemical mediators of GB dysmotility","volume":"11","author":"Pozo","year":"2012","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejphar.2021.174376_bib66","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.chroma.2010.10.116","article-title":"Differentiation of various traditional Chinese medicines derived from animal bile and gallstone\u00a0: simultaneous determination of bile acids by liquid chromatography coupled with triple quadrupole mass spectrometry","volume":"1218","author":"Qiao","year":"2011","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.ejphar.2021.174376_bib67","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s41048-020-00108-9","article-title":"C-reactive protein in GB diseases\u00a0: diagnostic and therapeutic insights","volume":"6","author":"Rajab","year":"2020","journal-title":"Biophys. Rep."},{"key":"10.1016\/j.ejphar.2021.174376_bib68","series-title":"PXR Prevents Cholesterol Gallstone Disease by Regulating Biosynthesis","first-page":"2095","author":"Regula","year":"2011"},{"key":"10.1016\/j.ejphar.2021.174376_bib69","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jff.2018.06.017","article-title":"Defatted walnut powder extract reduces cholesterol gallstones formation in C57BL\/6 mice by downregulating the levels of ABCG5\/8 in the liver and NPC1L1 in the intestine","volume":"48","author":"Ren","year":"2018","journal-title":"J. Funct. Foods"},{"key":"10.1016\/j.ejphar.2021.174376_bib70","first-page":"18","volume":"vol. 4","author":"Reshetnyak","year":"2012"},{"key":"10.1016\/j.ejphar.2021.174376_bib71","series-title":"Lifestyle and Gallstone Disease\u00a0: Scope for Primary Prevention","first-page":"263","volume":"36","author":"Sachdeva","year":"2011"},{"key":"10.1016\/j.ejphar.2021.174376_bib72","series-title":"Asymptomatic Cholelithiasis\u00a0: Is Cholecystectomy Really Needed\u00a0? A Critical Reappraisal 15 Years after the Introduction of Laparoscopic Cholecystectomy","first-page":"1313","author":"Sakorafas","year":"2007"},{"key":"10.1016\/j.ejphar.2021.174376_bib73","series-title":"Aggregated Neutrophil Extracellular Traps Limit Inflammation by Degrading Cytokines and Chemokines","first-page":"20","author":"Schauer","year":"2014"},{"key":"10.1016\/j.ejphar.2021.174376_bib74","first-page":"1","article-title":"Metabolic biomarkers and gallstone disease \u2013 a population-based study","author":"Shabanzadeh","year":"2017","journal-title":"Scand. J. Gastroenterol."},{"key":"10.1016\/j.ejphar.2021.174376_bib75","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.biopha.2007.12.008","article-title":"EGCG reducing the susceptibility to cholesterol gallstone formation through the regulation of inflammation","volume":"62","author":"Shan","year":"2008","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejphar.2021.174376_bib76","first-page":"33","article-title":"Cholelithiasis and Ayurveda","volume":"3","author":"Shankar","year":"2017","journal-title":"Int. J. Clin. Chem. Lab. Med."},{"key":"10.1016\/j.ejphar.2021.174376_bib77","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.ejphar.2015.01.038","article-title":"Piperine prevents cholesterol gallstones formation in mice","volume":"751","author":"Song","year":"2015","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2021.174376_bib78","series-title":"Epidemiology of GB Disease\u00a0: Cholelithiasis and Cancer","first-page":"172","volume":"6","author":"Stinton","year":"2012"},{"key":"10.1016\/j.ejphar.2021.174376_bib79","series-title":"Symptomatic, Non-complicated GB Stone Disease. Operation or Observation?","author":"Study","year":"2002"},{"key":"10.1016\/j.ejphar.2021.174376_bib80","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/s41430-018-0265-0","article-title":"Moderate, but not heavy, tea drinking decreased the associated risk of gallstones in a Taiwanese population","volume":"73","author":"Su","year":"2019","journal-title":"Eur. J. Clin. Nutr."},{"key":"10.1016\/j.ejphar.2021.174376_bib81","series-title":"Niemann\u2013Pick C1 like 1 gene expression is down-regulated by LXR activators in the intestine ' 340","first-page":"1259","author":"Tailleux","year":"2006"},{"key":"10.1016\/j.ejphar.2021.174376_bib82","series-title":"Reactive Oxygen Species and the Hypomotility of the Gall Bladder as Targets for the Treatment of Gallstones with Melatonin\u00a0: A Review","first-page":"2592","author":"Tamura","year":"2008"},{"key":"10.1016\/j.ejphar.2021.174376_bib83","first-page":"2423","article-title":"Intestinal cholesterol absorption is substantially reduced in mice deficient in both ABCA1 and","volume":"46","author":"Temel","year":"2005","journal-title":"ACAT2"},{"key":"10.1016\/j.ejphar.2021.174376_bib84","series-title":"Effect of Apricot Fruit and Kernel Extracts on In-vitro Dissolution of Cholesterol Gallstones\u00a0: Implication for Development of Potent Anti-Cholilithiaticc Agent","first-page":"755","volume":"54","author":"Tiwari","year":"2020"},{"key":"10.1016\/j.ejphar.2021.174376_bib85","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1002\/hep.22175","article-title":"Activation of liver X receptor sensitizes mice to GB cholesterol crystallization","volume":"47","author":"Uppal","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.ejphar.2021.174376_bib86","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S1590-8658(03)00086-0","article-title":"Intestinal aspects of cholesterol gallstone formation","volume":"35","author":"Van Erpecum","year":"2003","journal-title":"Dig. Liver Dis."},{"key":"10.1016\/j.ejphar.2021.174376_bib87","series-title":"Interactions between Bile Acids and Nuclear Receptors and Their Effects on Lipid Metabolism and Liver Diseases 2012","author":"Wang","year":"2012"},{"key":"10.1016\/j.ejphar.2021.174376_bib88","series-title":"Targeted Disruption of the Murine Mucin Gene 1 Decreases Susceptibility to Cholesterol Gallstone Formation 1 45","author":"Wang","year":"2004"},{"key":"10.1016\/j.ejphar.2021.174376_bib89","series-title":"Evidence that GB Epithelial Mucin Enhances Cholesterol Cholelithogenesis in MUC1 Transgenic Mice","first-page":"210","author":"Wang","year":"2006"},{"key":"10.1016\/j.ejphar.2021.174376_bib90","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1053\/j.gastro.2008.03.011","article-title":"Effect of ezetimibe on the prevention and dissolution of cholesterol gallstones","volume":"134","author":"Wang","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejphar.2021.174376_bib91","series-title":"Intestinal Flora Imbalance Affects Bile Acid Metabolism and Is Associated with Gallstone Formation","first-page":"1","author":"Wang","year":"2020"},{"key":"10.1016\/j.ejphar.2021.174376_bib92","series-title":"Serum Adiponectin Levels in Cholesterol and Pigment Cholelithiasis","first-page":"981","author":"Wang","year":"2006"},{"key":"10.1016\/j.ejphar.2021.174376_bib93","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.amjsurg.2009.01.014","article-title":"Visfatin \u2014 a proinflammatory adipokine \u2014 in gallstone disease","volume":"199","author":"Wang","year":"2010","journal-title":"AJS"},{"key":"10.1016\/j.ejphar.2021.174376_bib94","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1093\/ajcn\/nqaa154","article-title":"A healthy lifestyle pattern and the risk of symptomatic gallstone disease: results from 2 prospective cohort studies","volume":"112","author":"Wirth","year":"2020","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.ejphar.2021.174376_bib95","series-title":"Impaired Cytoprotective Function of Muscle in Human GBs with Cholesterol Stones","first-page":"525","author":"Xiao","year":"2005"},{"key":"10.1016\/j.ejphar.2021.174376_bib96","series-title":"Role of PGE 2 on GB Muscle Cytoprotection of guinea Pigs","first-page":"82","author":"Xiao","year":"2004"},{"key":"10.1016\/j.ejphar.2021.174376_bib97","series-title":"Role of Caveolae in the Pathogenesis of Cholesterol-Induced GB Muscle Hypomotility 02903","first-page":"1641","author":"Xiao","year":"2007"},{"key":"10.1016\/j.ejphar.2021.174376_bib98","series-title":"Postcholecystectomy Syndrome, StatPearls","author":"Zackria","year":"2021"},{"key":"10.1016\/j.ejphar.2021.174376_bib99","first-page":"3089","volume":"vol. 3094","author":"Zhang","year":"2006"},{"key":"10.1016\/j.ejphar.2021.174376_bib100","doi-asserted-by":"crossref","first-page":"154728","DOI":"10.1016\/j.metabol.2021.154728","article-title":"Glucagon-like peptide 1 analogue prevents cholesterol gallstone formation by modulating intestinal farnesoid X receptor activity","volume":"118","author":"Zhang","year":"2021","journal-title":"Metabolism"},{"key":"10.1016\/j.ejphar.2021.174376_bib101","first-page":"73","volume":"vol. 31","author":"Zhao","year":"2016"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001429992100529X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001429992100529X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T22:58:36Z","timestamp":1757977116000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001429992100529X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":101,"alternative-id":["S001429992100529X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2021.174376","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recent advances, novel targets and treatments for cholelithiasis; a narrative review","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2021.174376","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"174376"}}